Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 375,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 375,000 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 300,000 | n/a |
| Nov 12, 2024 | Celldex Therapeutics, Inc. (CLDX) | Purchase | 11,500 | $308.4K |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 300,000 | n/a |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 250,000 | n/a |
| Aug 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 75,000 | $208.5K |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 250,000 | n/a |
| Aug 9, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 3,537 | $148.6K |
| Jun 21, 2021 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 224,000 | n/a |
| Jun 19, 2020 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 245,000 | n/a |